UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (23), p.6964-6974

2016

Link zum Volltext

Verfügbarkeit prüfen

The complementarity of DDR, nucleic acids and anti-tumour immunity

Nature (London), 2023-07, Vol.619 (7970), p.475-486

2023

Link zum Volltext

Verfügbarkeit prüfen

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

The Journal of clinical investigation, 2011-06, Vol.121 (6), p.2371-2382

2011

Link zum Volltext

Verfügbarkeit prüfen

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells

Cancer discovery, 2017-01, Vol.7 (1), p.72-85

2017

Link zum Volltext

Verfügbarkeit prüfen

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

Nature communications, 2017-06, Vol.8 (1), p.15908-12, Article 15908

2017

Link zum Volltext

Verfügbarkeit prüfen

Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism

Cancer research (Chicago, Ill.), 2015-02, Vol.75 (3), p.519-531

2015

Link zum Volltext

Verfügbarkeit prüfen

Tregs and rethinking cancer immunotherapy

The Journal of clinical investigation, 2007-05, Vol.117 (5), p.1167-1174

Curiel, Tyler J

2007

Link zum Volltext

Verfügbarkeit prüfen

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer

Oncoimmunology, 2018-11, Vol.7 (11), p.e1500107-e1500107

2018

Link zum Volltext

Verfügbarkeit prüfen

CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (22), p.5063-5075

2020

Link zum Volltext

Verfügbarkeit prüfen

Graft-versus-host disease is enhanced by selective CD73 blockade in mice

PloS one, 2013-03, Vol.8 (3), p.e58397-e58397

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents

International journal of molecular sciences, 2022-05, Vol.23 (9), p.5129

2022

Link zum Volltext

Verfügbarkeit prüfen

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

Nature medicine, 2001-12, Vol.7 (12), p.1339-1346

2001

Link zum Volltext

Verfügbarkeit prüfen

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Experimental gerontology, 2018-05, Vol.105, p.146-154

2018

Link zum Volltext

Verfügbarkeit prüfen

Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2089-2099

2012

Link zum Volltext

Verfügbarkeit prüfen

B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses

The Journal of immunology (1950), 2010-09, Vol.185 (5), p.2747-2753

2010

Link zum Volltext

Verfügbarkeit prüfen

Optimization of immunotherapy in elderly cancer patients

Critical reviews in oncogenesis, 2013, Vol.18 (6), p.573

2013

Link zum Volltext

Verfügbarkeit prüfen

Regulatory T cells and treatment of cancer

Current opinion in immunology, 2008-04, Vol.20 (2), p.241-246

Curiel, Tyler J

2008

Link zum Volltext

Verfügbarkeit prüfen

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer medicine (Malden, MA), 2021-03, Vol.10 (6), p.2137-2152

2021

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

Oncoimmunology, 2019-08, Vol.8 (8), p.1614857-1614857

2019

Link zum Volltext

Verfügbarkeit prüfen

Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial

Clinical cancer research, 2015-01, Vol.21 (2), p.303-311

2015

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e001932

2021

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (16), p.5535-5538

2004

Link zum Volltext

Verfügbarkeit prüfen

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer

Signal transduction and targeted therapy, 2016-01, Vol.1 (1), p.16030, Article 16030

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation

Journal for immunotherapy of cancer, 2020-08, Vol.8 (2), p.e000964

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(197)

Publikationsform

Artikel
(207)
Buchkapitel
(3)

Sprache

Englisch
(210)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma

The complementarity of DDR, nucleic acids and anti-tumour immunity

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

Interventions to Slow Aging in Humans: Are We Ready?

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism

Tregs and rethinking cancer immunotherapy

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer

CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade

Graft-versus-host disease is enhanced by selective CD73 blockade in mice

Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice

B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses

Optimization of immunotherapy in elderly cancer patients

Regulatory T cells and treatment of cancer

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial

Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer

Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation

Suchergebnisse filtern